In the present era, Metabolic disorder is a challenge to the medical community because of its increasing prevalence and unsatisfactory management. There is no permanent remedy, and the patient has to continue the medicine for a longer life. According to Ayurveda, all metabolic diseases are caused due to Jathragnimandya(improper digestion & metabolism). Hence the correction of Agni is the principle to treat it. Various herbs act as agnivardhak (increase digestive fire or Rasayan (Rejuvenator). Haridra (Curcuma longa) and Amalaki (Emblica Officinalis) are the herbal drugs recommended in Ayurveda literature. Ayurveda practitioners are using these medicines for various metabolic disorders. Hence this review was carried out to discover their utility in metabolic disorders. The aim and objective of this review are to study the role of common herbs available worldwide, which are Haridra (Curcuma longa) and Amalaki (Emblicaofficinalis), in metabolic disorders. The related data were collected from classical texts of Ayurveda, google scholar, and PubMed. A total of 10 articles were considered for review. Out of these, four were animal studies, and six were analytical studies in which the assessment parameters were fasting. From this review, few studies have been conducted on only Haridra as compared to Amalaki on the post-meal blood sugar levels, glycolatedhaemoglobin (HbA1c) levels, oral glucose tolerance test, and complete blood count metabolic disorders. The maximum studies are on Nisha-Amalaki(a combination of Haridra&Amalakialongwith bhavna[trituration process] of Amalakiswarasa[Juice form of Emblicaofficinalis]to Haridra[Curcuma longa]) which is found to be effective in Diabetes mellitus and dyslipidemia, which can be considered as the cavity of previous reviews. Therefore, there is a need to conduct studies on Nisha-amalaki to explore its effect on other common metabolic disorders like PCOD, Hypothyroidism.
Avascular necrosis is a pathological condition caused by a limitation in the microcirculation of the bone, causing its necrosis. Avascular necrosis (AVN)of the hip is a common condition that creates complex symptoms characterized by pain, impaired function, and structural breakdown. According to Ayurveda, it can be correlated with AsthimajjagatVata, which occurs due to the Akshaya(destruction)of Asthi and Majjadhatus. The present case report is of a 32-years old male patient diagnosed with Avascular necrosis of StageIII of the right hip and Stage II of the left hip as per Ficat and Arlet's classification of Avascular necrosis. He complained of pain in both hips, associated with the inability to walk a short distance and difficulty sitting without back support. The patient was treated considering the involvement of Vata dosha, Asthi-majjadhatu, and raktavahastrotodushti. The treatment protocol adopted in modern medicine for the management of Avascular necrosis is corticosteroids and hip replacement surgery. Hence, there is a need to encourage classical Ayurveda modalities like Shodhan and Shaman to manage Avascular necrosis. The main aim of this study is to assess the effectiveness of classical Ayurveda remedies in managing Asthimajjagat Vata in a patient with Avascular necrosis. In this case, the treatment was planned considering the predominant involvement of Vata dosha, Asthi & Majjadhatu, and Strotorodha. He was treated by applying the treatment principles of Asthi-majjagatkshaya caused due to Margavrodhjanya Vataprakopa. This case is being reported because it shows how combining the Ayurveda principles of Shodhan and Shaman was used. As a result, it significantly improved hip joints' walking, sitting, and movement. This case may motivate Ayurveda researchers to work on AVN.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.